Scoping review of secondary studies using the Federal Interagency of Traumatic Brain Injury Research datasets.
Amanda N Fitterer, Leila Ledbetter, Peter Duquette and 4 others
PMID 41657011WHAT IT FOUND
A scoping review of 49 studies found that researchers rarely combine multiple datasets when analyzing traumatic brain injury data, likely due to inconsistent data collection forms.
Most studies rely on a single dataset, limiting the potential for large-scale comparisons across different patient groups.
Key findings
01Of the 49 included studies, 33 relied on a single dataset, while only a few used two or more datasets for their analyses.
02The lack of uniformity in data collection instruments makes it difficult to perform secondary analysis on data aggregated from multiple studies.
03Despite recommendations for common data elements, 982 different forms have been listed in the repository, with 587 form structures used in only one study each.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The review may have missed relevant articles because it excluded conference and supplementary abstracts, which often present preliminary findings. Non-English articles were excluded due to a lack of translation resources, potentially limiting the comprehensiveness of the review. Quality appraisal was not conducted, so the methodological rigor of the included studies was not assessed. The number of shared studies in FITBIR is growing rapidly, so the landscape of available data may have changed since the search dates.
Declared interests
The authors declared no competing interests.
The easy way to misread this
Do not interpret this as evidence that combining datasets is clinically ineffective or impossible; rather, it reports that researchers currently avoid doing so because the underlying data collection methods are inconsistent. The review describes the state of data science infrastructure, not the efficacy of any specific therapy.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →